Molecular Detection Reimagined
Next-Generation Molecular Detection Platform
XPOTDx is developing a next-generation molecular detection platform based on HFF-QCMD high-frequency acoustic array technology, enabling ultra-sensitive, multiplexed and label-free biomolecular analysis across research and precision diagnostics. Our platform transforms molecular interactions into measurable acoustic signals, creating new opportunities for biomarker discovery, molecular characterization and precision diagnostics.
24 sensors per HFF-QCMD array
for simultaneous readouts
0.01%
ctDNA sensitivity matching dPCR
Results in ~2 Hours
From blood collection to ctDNA detection in just ~2 hours, enabling real-time cancer monitoring and faster clinical decision-making.
APPLICATIONS
Cancer Monitoring & Early Cancer Detection Liquid Biopsy
Track disease progression and treatment response in real time. Detect cancer earlier with ultra-sensitive ctDNA analisys
Biomarkers validation platform
Accelerate the discovery and validation of molecular biomarkers
Therapy Response and Resistance
Identify emerging resistance mutations to guide treatment decisions
Minimal Residual Disease (MDR) Detection
Detect residual disease at ultra-low level to predict relapse
Antimicrobial Resistance Genes
Detect and monitor antibiotic resistance genes in clinical and environmental samples
